FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula III, where independently for each occurrence, R2 is halogen; R3 is C1-6 aliphatic group substituted with OP; P is acetyl, benzoyl, benzyl, β-methoxyethoxymethyl ester, dimethoxytrityl, methoxymethyl ester, methoxytrityl, para-methoxybenzyl ether, pivaloyl, tetrahydropyranyl, trityl and trimethylsilyl; and o is 1.
EFFECT: obtaining a novel intermediate compound, which is applicable for producing (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, which in turn can be used in medicine for treating CFTR mediated diseases, such as cystic fibrosis.
3 cl, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2011 |
|
RU2569678C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2012 |
|
RU2640420C2 |
SOLID FORMS OF (R)-1-(2, 2-DIFLUOROBENZO[D][1, 3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE | 2011 |
|
RU2711481C2 |
SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE | 2011 |
|
RU2573830C2 |
SOLID FORMS OF 3-(2, 2-DIFLUOROBENZO[D][1,3] DIOXOL-5-YL)CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID | 2011 |
|
RU2579370C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING CFTR MEDIATED DISEASES | 2014 |
|
RU2718044C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING 3-(2, 2-DIFLUOROBENZO[d][1, 3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID, AND ADMINISTRATION THEREOF | 2011 |
|
RU2592368C2 |
METHOD OF OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2543714C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2015 |
|
RU2744460C2 |
Authors
Dates
2021-04-05—Published
2011-04-21—Filed